View this video:
OPTIMIZERx's Five Tips to Save on your Prescriptions
Eighty-one Articles match your search
Less HRT, Fewer Cases of Possible Breast Cancer Precursor
November 12, 2009
As hormone use declined, so did incidence of abnormal cells in milk ducts, study finds. Declining use of hormone replacement therapy may be driving down rates of a condition called "atypical ductal hyperplasia," a known risk factor for breast cancer, new research suggests.
This is the first time a link has been found between atypical ductal hyperplasia .
This is the first time a link has been found between atypical ductal hyperplasia .
Hormone Therapy Can Help Some With Prostate Cancer
November 02, 2009
But often not needed for early-stage patients, long-running study shows A brief course of hormone-blocking therapy can provide small benefits to a specific group of men who get radiation therapy for prostate cancer, a long-running study shows.
Ten-year survival was 62 percent in men with cancers graded as intermediate risk who got treatment that blocked their male hormone activity in addition to radiation therapy, compared to 57 percent of those who got radiation therapy alone, said Dr. Christopher U.
Ten-year survival was 62 percent in men with cancers graded as intermediate risk who got treatment that blocked their male hormone activity in addition to radiation therapy, compared to 57 percent of those who got radiation therapy alone, said Dr. Christopher U.
Testicular Cancer Survivors Face Other Ills
October 28, 2009
Treatment can cause long-term neurological, circulatory problems, study finds. For men with testicular cancer, survival comes at a price: New research suggests that those who recover from the disease face higher risks of long-term illness unrelated to tumors.
"Current patients with testicular cancer should be informed about the risk of short-term and particularly long-term side effects of their highly effective treatment," said Sophie D. Fossa, a professor at the University of Oslo in Norway and lead author of a study in the November issue of the journal BJUI.
"Current patients with testicular cancer should be informed about the risk of short-term and particularly long-term side effects of their highly effective treatment," said Sophie D. Fossa, a professor at the University of Oslo in Norway and lead author of a study in the November issue of the journal BJUI.
With Hormone Therapy, Tender Breasts May Signal Cancer Risk
October 12, 2009
Symptom might warrant a reassessment of treatment, experts suggest. Breast tenderness in women taking estrogen/progestin hormone replacement therapy could signal increased chances of developing breast cancer, a new study says.
Women taking estrogen plus progestin who reported developing breast tenderness after starting the hormone therapy were 48 percent more likely to develop invasive breast cancer than women on hormone therapy who did not experience breast tenderness.
Researchers said more study is needed before they would recommend that women who experience this symptom discontinue taking the hormones.
Women taking estrogen plus progestin who reported developing breast tenderness after starting the hormone therapy were 48 percent more likely to develop invasive breast cancer than women on hormone therapy who did not experience breast tenderness.
Researchers said more study is needed before they would recommend that women who experience this symptom discontinue taking the hormones.
Hormone Therapy for Prostate Cancer Raises Heart Risks
September 22, 2009
Treatment methods should take into account side effects, researchers say. Hormone therapy to treat advanced prostate cancer can increase the risk of heart disease, but some types of hormone therapy appear to be safer than others, new research has found.
The study included 30,642 Swedish men with either locally advanced prostate cancer or prostate cancer that had spread (metastatic cancer), who had received hormone therapy as primary treatment for their cancer.
The study findings were scheduled to be presented Tuesday at the European Cancer Organization meeting in Berlin.
The study included 30,642 Swedish men with either locally advanced prostate cancer or prostate cancer that had spread (metastatic cancer), who had received hormone therapy as primary treatment for their cancer.
The study findings were scheduled to be presented Tuesday at the European Cancer Organization meeting in Berlin.
Hormone Therapy May Make Lung Cancer More Likely
September 20, 2009
Expert says finding supports doubts about value of treatment. Taking a combination form of hormone replacement therapy, which includes both estrogen and progestin, increases a woman's risk for dying from lung cancer, a new study has found.
The finding stems from an analysis of data from the Women's Health Initiative trial on 16,608 postmenopausal women, aged 50 to 79, in the United States who had been randomly assigned to take either a once-daily tablet of 0.625 milligrams conjugated equine estrogen plus 2.
The finding stems from an analysis of data from the Women's Health Initiative trial on 16,608 postmenopausal women, aged 50 to 79, in the United States who had been randomly assigned to take either a once-daily tablet of 0.625 milligrams conjugated equine estrogen plus 2.
Timing, Type of HRT May Determine Breast Cancer Risk
September 16, 2009
Starting estrogen-progestagen therapy early may up odds of disease, study shows. The timing and type of hormone replacement therapy women take to relieve menopausal symptoms seem to determine the degree of breast cancer risk they face, a new French study suggests.
Overall, starting estrogen-progestagen therapy soon after menopause appears to boost the risk of breast cancer, even when only used for short periods of time, according to the study, which was published in the Sept. 14 online issue of the Journal of Clinical Oncology.
Overall, starting estrogen-progestagen therapy soon after menopause appears to boost the risk of breast cancer, even when only used for short periods of time, according to the study, which was published in the Sept. 14 online issue of the Journal of Clinical Oncology.
Acupuncture May Help Relieve Polycystic Ovary Syndrome
September 04, 2009
Exercise also improves symptoms and related risk factors, study finds. Acupuncture and exercise may help women better handle the symptoms and risks that come with hormone imbalances caused by certain ovarian cysts, Swedish researchers report.
About one in 10 women of reproductive age have polycystic ovarian syndrome, a condition that can start in the teen years and cause irregular menstrual cycles and infertility. Small immature cysts on the ovaries disrupt hormone production, causing excessive secretion of testosterone, the male sex hormone.
About one in 10 women of reproductive age have polycystic ovarian syndrome, a condition that can start in the teen years and cause irregular menstrual cycles and infertility. Small immature cysts on the ovaries disrupt hormone production, causing excessive secretion of testosterone, the male sex hormone.
Testosterone Therapy May Help Men With Heart Failure
August 24, 2009
Injections of male hormone boosted cardiac performance in Italian study. Injections of the male hormone testosterone increased blood-pumping ability and heart muscle strength in men with heart failure, Italian researchers report.
"From our study, it appears that testosterone supplementation is useful for both patients with low and normal testosterone levels, although the improvements are greater in those with low levels," said Dr. Ferdinando Iellamo, an assistant professor of internal medicine at the University of Rome Tor Vergata, and lead author of a report in the Sept.
"From our study, it appears that testosterone supplementation is useful for both patients with low and normal testosterone levels, although the improvements are greater in those with low levels," said Dr. Ferdinando Iellamo, an assistant professor of internal medicine at the University of Rome Tor Vergata, and lead author of a report in the Sept.
Testosterone Influences Women's Career Moves
August 24, 2009
Those with higher levels of the male hormone take more risks, research finds. Higher testosterone levels may make some women more likely to choose high-risk financial careers, a U.S. study suggests.
Sex Hormone Levels Linked to Fractures in Men
August 14, 2009
Testing for estradiol, testosterone and SHBG could predict those at risk, expert says. Sex hormone levels affect the risk of broken bones in older men, says a new study.
The finding comes from a study that included 1,436 men age 65 and older who had their sex hormone levels measured periodically for about five years. The researchers found that men with low levels of estradiol or high levels of sex hormone binding globulin (SHBG) were more likely to suffer osteoporotic fractures.
The finding comes from a study that included 1,436 men age 65 and older who had their sex hormone levels measured periodically for about five years. The researchers found that men with low levels of estradiol or high levels of sex hormone binding globulin (SHBG) were more likely to suffer osteoporotic fractures.
In U.S., No Comeback Seen for Hormone Therapy
August 09, 2009
Experts say risks of long-term use still outweigh possible benefits. Hormone replacement therapy once seemed like a wonderful means to help women age gracefully. By dosing menopausal women with estrogen and progesterone as their bodies began to produce decreased amounts of those hormones, doctors believed they could help fend off heart disease, osteoporosis and cancer.
But those beliefs collapsed in 2002, when researchers pulled the plug three years early on the Women's Health Initiative, a large-scale, federally funded study of hormone replacement therapy (HRT).
But those beliefs collapsed in 2002, when researchers pulled the plug three years early on the Women's Health Initiative, a large-scale, federally funded study of hormone replacement therapy (HRT).
Hormone Therapy Increases Odds of Ovarian Cancer
July 14, 2009
But risk remains low and decreases two years after stopping, study finds. Women who take hormone replacement therapy or have taken it in the recent past have a higher risk of developing ovarian cancer, suggests new research.
In a large Danish study, compared to women who never took hormone replacement therapy, current users had a 38 percent increased risk of ovarian cancer and a 44 percent increased risk of epithelial ovarian cancer, which is cancer that begins on the outer lining of the ovary. The results were reported in the July 15 issue of the Journal of the American Medical Association.
In a large Danish study, compared to women who never took hormone replacement therapy, current users had a 38 percent increased risk of ovarian cancer and a 44 percent increased risk of epithelial ovarian cancer, which is cancer that begins on the outer lining of the ovary. The results were reported in the July 15 issue of the Journal of the American Medical Association.
Another Genetic Link to Testicular Cancer Is Found
July 02, 2009
Discovery may help explain why disease runs in families. A second gene linked to inherited testicular germ-cell cancer has been identified by scientists at the U.S. National Institutes of Health.
Breast Cancer Numbers Dip Most in Wealthy, Urban Areas
June 26, 2009
Hormone-replacement therapy probably accounts for differences between rich and poor women: study. Cases of invasive breast cancer in the United States have declined overall, but the decrease is significantly less marked in poor women who live in rural areas, possibly due to differences in the use of hormone therapy (HT), a new study suggests.
Researchers at the Northern California Cancer Center studied national breast cancer incidence data for the years 1997 to 2004 to compare rates in rural and urban areas and poor and rich areas of the country.
"Between 2001 and 2004, incidence rates of invasive breast cancer declined more than 8 percent in the United States," study leader Christina Clarke said in a news release.
Researchers at the Northern California Cancer Center studied national breast cancer incidence data for the years 1997 to 2004 to compare rates in rural and urban areas and poor and rich areas of the country.
"Between 2001 and 2004, incidence rates of invasive breast cancer declined more than 8 percent in the United States," study leader Christina Clarke said in a news release.
Blood-Sugar Spikes Send Testosterone Levels Down
June 13, 2009
Finding has implications for men with low levels of the hormone, experts say. Post-meal surges in blood sugar can cut a man's level of circulating testosterone by about a quarter, new research shows.
The finding might help doctors decide to test for testosterone levels while patients are fasting, the researchers said.
The study, slated for presentation Saturday at The Endocrine Society's annual meeting in Washington, D.
The finding might help doctors decide to test for testosterone levels while patients are fasting, the researchers said.
The study, slated for presentation Saturday at The Endocrine Society's annual meeting in Washington, D.
Pausing Hormone Therapy Doesn't Cut Mammogram Recalls
June 03, 2009
Repeat imaging rates similar whether women stopped hormone treatment or not, study finds. Taking a break from hormone therapy before a mammogram doesn't lower the likelihood of being called back for extra imaging, a study including more than 1,700 women aged 45 to 80 has found.
"Postmenopausal hormones make breasts denser .
"Postmenopausal hormones make breasts denser .
Researchers Spot Genes Linked to Testicular Cancer
June 01, 2009
Discovery could help determine which men are at increased risk, scientists say. U.S. scientists say they've identified key gene variants tied to an increased risk of testicular cancer.
HRT Ups Death Risk for Women With Lung Cancer
June 01, 2009
Shortened survival points to estrogen's potential role in the disease, experts say. The current use of combined hormone replacement therapy (HRT) is associated with a higher risk of dying for women diagnosed with non-small cell lung cancer, a new study shows.
The risk was highest in current smokers, less high in former smokers and least high in women who never smoked, say researchers reporting Saturday at the annual meeting of the American Society of Clinical Oncology (ASCO), in Orlando, Fla.
"This is a major concern," said study lead author Dr.
The risk was highest in current smokers, less high in former smokers and least high in women who never smoked, say researchers reporting Saturday at the annual meeting of the American Society of Clinical Oncology (ASCO), in Orlando, Fla.
"This is a major concern," said study lead author Dr.
Testosterone Injections Offer Hope for Male Contraceptive
May 05, 2009
Possible alternative to current birth control methods needs more study. Injectable testosterone may be an effective form of male contraception, new research suggests.
Chinese researchers injected 1,045 healthy, fertile Chinese men aged 20 to 45 years with a 500 milligram formulation of testosterone undecanoate in tea seed oil once a month for 30 months.
All of the study participants had a normal medical history and had fathered at least one child within two years of beginning the study.
Chinese researchers injected 1,045 healthy, fertile Chinese men aged 20 to 45 years with a 500 milligram formulation of testosterone undecanoate in tea seed oil once a month for 30 months.
All of the study participants had a normal medical history and had fathered at least one child within two years of beginning the study.
Heart, Bone Problems May Follow Prostate Cancer Treatment
April 27, 2009
Men on hormone-lowering therapy may require close monitoring, researchers say. Though proven effective, treating prostate cancer with the testosterone-lowering treatment known as androgen deprivation therapy may raise men's risk for developing bone fractures and fatal cardiovascular disease, a new study suggests.
The likelihood of developing either side effect remains low, the researchers noted. But the study shines fresh light on the question of how best to weigh the potential benefits of androgen deprivation therapy (ADT) against the potentially serious complications that can ensue.
The likelihood of developing either side effect remains low, the researchers noted. But the study shines fresh light on the question of how best to weigh the potential benefits of androgen deprivation therapy (ADT) against the potentially serious complications that can ensue.
HRT May Protect Women From Colon Cancer
April 22, 2009
Finding echoes earlier research involving hormone therapy. Older women using hormone replacement therapy appear to have a 28 percent reduction in their risk of developing colorectal cancer, a new study found.
But researchers don't yet know why the link seems to exist. And the main message to women remains the same: Take hormone replacement therapy at the lowest dose possible for the shortest period of time possible and only for menopausal symptoms such as hot flashes.
But researchers don't yet know why the link seems to exist. And the main message to women remains the same: Take hormone replacement therapy at the lowest dose possible for the shortest period of time possible and only for menopausal symptoms such as hot flashes.
Soy May Not Lead to Denser Breasts
April 22, 2009
Study finds no link to condition that can increase cancer risk. Soy isoflavones don't increase breast density, a new study finds.
That's good news because it's believed that increased breast density is associated with a higher risk of breast cancer. A number of studies have suggested that dietary factors, including isoflavones (estrogen-like plant compounds) might increase breast density.
That's good news because it's believed that increased breast density is associated with a higher risk of breast cancer. A number of studies have suggested that dietary factors, including isoflavones (estrogen-like plant compounds) might increase breast density.
Dense Breasts Complicate Testing and Treatment
April 16, 2009
Risk factor is one women can do little about, experts say. For years, researchers have known that breast density is almost as important as age in predicting who will develop breast cancer.
But now they're discovering how the density of a woman's breast tissue can also predict how she will respond to cancer treatment and whether her cancer will recur.
The denser a woman's breasts, the less fat they have, explained Diana Buist, an epidemiologist at Group Health Center for Health Studies in Seattle.
But now they're discovering how the density of a woman's breast tissue can also predict how she will respond to cancer treatment and whether her cancer will recur.
The denser a woman's breasts, the less fat they have, explained Diana Buist, an epidemiologist at Group Health Center for Health Studies in Seattle.
Acupuncture May Not Help Hot Flashes
April 07, 2009
Most data finds no difference between real, sham treatments, researchers say. Acupuncture appears ineffective in treating menopause-related hot flashes, according to researchers who reviewed six randomized controlled studies that compared the effects of real acupuncture and sham acupuncture.
Only one of the studies found that acupuncture helped reduce the frequency and severity of hot flashes at four weeks follow-up after treatment.
The number of good randomized controlled trials is too small to draw any firm conclusion about whether acupuncture helps treat hot flashes, but the evidence from the studies suggests the treatment is ineffective, said lead researcher Dr.
Only one of the studies found that acupuncture helped reduce the frequency and severity of hot flashes at four weeks follow-up after treatment.
The number of good randomized controlled trials is too small to draw any firm conclusion about whether acupuncture helps treat hot flashes, but the evidence from the studies suggests the treatment is ineffective, said lead researcher Dr.
Male Infertility Tied to Testicular Cancer Risk
February 23, 2009
A common factor may boost the odds for both, researchers say. Infertile men may be at increased risk for testicular cancer, U.S. researchers report.
One in Three Cancer Survivors on Unemployment Line
February 17, 2009
Lingering physical effects of cancer a likely cause, study finds. As if fighting cancer wasn't hard enough, a new Dutch study concludes that one in three people who survive the ordeal won't be able to find a job.
The meta-analysis of more than 20,000 cancer survivors found that 33.8 percent of those who'd battled cancer were out of work vs.
The meta-analysis of more than 20,000 cancer survivors found that 33.8 percent of those who'd battled cancer were out of work vs.
Marijuana Linked to Aggressive Testicular Cancer
February 09, 2009
But not all are sure that adolescents' use of cannabis causes cells to proliferate. Smoking marijuana over an extended period of time appears to greatly boost a young man's risk for developing a particularly aggressive form of testicular cancer, a new study reveals.
In fact, researchers found that men who smoked marijuana once a week or began to use the substance on a long-term basis while adolescents incurred double the risk for developing the fastest-spreading version of testicular cancer .
In fact, researchers found that men who smoked marijuana once a week or began to use the substance on a long-term basis while adolescents incurred double the risk for developing the fastest-spreading version of testicular cancer .
Drop in Breast Cancer Rates Due to Drop in HRT Use
February 04, 2009
Researchers say first two years of combined hormone therapy a 'safe' period. A new analysis shows that the drop in breast cancer cases that began in 2003 is indeed due to women stopping hormone replacement therapy (HRT) after a large, U.S. study showed surprisingly higher rates of heart problems and breast cancer among users of some kinds of HRT.
2 Years of Hormone Use May Be 'Safe'
February 03, 2009
Cancer risk doesn't rise until third year, study finds. A potential two-year "safe period" for hormone replacement therapy has been identified by American Cancer Society epidemiologists, who also confirmed that using estrogen-plus-progesterone therapy increases the risk for both ductal and lobular breast cancer far more than taking estrogen alone.
The finding follows a report last month from the Society of Obstetricians and Gynaecologists of Canada that women have been needlessly scared away from using hormone therapy during menopause.
Researchers for the U.
The finding follows a report last month from the Society of Obstetricians and Gynaecologists of Canada that women have been needlessly scared away from using hormone therapy during menopause.
Researchers for the U.
The Truth About 'Bio-identical' Hormone Therapy
January 30, 2009
Much remains unknown about these treatments for menopausal symptoms, FDA says. They're marketed as "bio-identical" hormones or "bio-identical hormone replacement therapy," and they claim to do everything from helping menopausal women lose weight to preventing senility.
They're touted as safer and sometimes even more effective than conventional hormone-replacement therapy.
But the U.
They're touted as safer and sometimes even more effective than conventional hormone-replacement therapy.
But the U.
In High-Stakes Stock Trading, Finger Length Matters
January 12, 2009
Study finds testosterone exposure in womb creates long ring finger, financial success For all those whose ring finger far outstretches their index finger, British researchers have pinpointed the perfect job: high-volume stock trader.
According to a new study, having a relatively long ring finger augurs well for success in those high-stress financial arenas where fast thinking, good reflexes and good old-fashioned guts matter most. A lengthy fourth digit, the authors note, indicates greater exposure to testosterone in the womb, which in turn gives what they call "high-frequency" traders a biological leg up by encouraging the development of the right mix of mental attitude and physical skills for making money in a cutthroat business.
According to a new study, having a relatively long ring finger augurs well for success in those high-stress financial arenas where fast thinking, good reflexes and good old-fashioned guts matter most. A lengthy fourth digit, the authors note, indicates greater exposure to testosterone in the womb, which in turn gives what they call "high-frequency" traders a biological leg up by encouraging the development of the right mix of mental attitude and physical skills for making money in a cutthroat business.
HRT Shrinks the Brain
January 12, 2009
But research shows it does not damage cerebral blood vessels in older women. Two studies looking at the same group of women found that while hormone therapy is linked with brain shrinkage, it does not seem to be associated with early signs of cerebrovascular disease.
This suggests that hormone therapy's effect on brain volume, not its effect on the brain lesions that indicate "silent strokes," is the mechanism by which hormones increase the risk for dementia in women over 65.
"These are a nice companion to cognitive studies reported earlier.
This suggests that hormone therapy's effect on brain volume, not its effect on the brain lesions that indicate "silent strokes," is the mechanism by which hormones increase the risk for dementia in women over 65.
"These are a nice companion to cognitive studies reported earlier.
Hormone Therapy May Cut Colorectal Cancer Risk
January 08, 2009
Study included nearly 57,000 women who had been followed for about 15 years. Hormone therapy may lower a woman's risk of colorectal cancer, especially if she is no longer taking the hormones.
This new finding, published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, further complicates an already murky picture of the risks and benefits of hormone replacement therapy (HRT).
Previous landmark research has shown an increased risk of breast cancer and cardiovascular problems, but a lowered risk of colon cancer.
This new finding, published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, further complicates an already murky picture of the risks and benefits of hormone replacement therapy (HRT).
Previous landmark research has shown an increased risk of breast cancer and cardiovascular problems, but a lowered risk of colon cancer.
Obesity Linked to Ovarian Cancer
January 05, 2009
Excess estrogen may contribute to malignancy, study suggests. Obese postmenopausal women who have never used hormone replacement therapy may face an increased risk of ovarian cancer, compared to normal-weight women, a new study suggests.
Interestingly, obese women who have used hormone replacement therapy (HRT) for symptoms of menopause may not face increased risk for this type of malignancy.
The study findings are published in the Feb.
Interestingly, obese women who have used hormone replacement therapy (HRT) for symptoms of menopause may not face increased risk for this type of malignancy.
The study findings are published in the Feb.
HRT Users Who Get Breast Cancer Less Likely to Die
December 12, 2008
They tend to get type of tumors that have better prognosis, study finds. Taking hormone therapy after menopause is known to increase the risk of getting breast cancer, but women who take hormone therapy and then develop breast cancer have a lower risk of dying from the disease, a new study suggests.
Why?
"Hormone therapy seems to give you a particular type of cancer that is easier to treat," explained study author Sarah F. Marshall, a senior statistician at the University of California Irvine.
Why?
"Hormone therapy seems to give you a particular type of cancer that is easier to treat," explained study author Sarah F. Marshall, a senior statistician at the University of California Irvine.
Preeclampsia Might Protect Against Testicular Cancer
October 31, 2008
Study suggests link between high blood pressure in pregnancy and risk of the malignancy. Pregnant women who experience severe high blood pressure may find that their risky condition ultimately helps protect their sons from testicular cancer, a new study suggests.
Successive Births, HRT Use Boost Joint Replacement Risks
October 28, 2008
Early puberty also a factor in increased chance of knee, hip surgeries, study finds. Early puberty, having lots of children, and hormone replacement therapy all increase a woman's likelihood of having knee or hip replacement surgery, according to a study that looked at 1.3 million British women whose health was tracked for an average of six years after they turned 50.
Women Smokers Prone to Dangerous Blood Vessel Condition
October 15, 2008
Women who smoke are eight times more likely to suffer a potentially fatal rupture of the body's largest artery, or require surgery to repair the weakening that can cause such a rupture, than nonsmokers.
Prostate Meds Not Tied to Increased Hip Fracture Risk
October 07, 2008
But long-term effects of hormone-blocking drugs still need review, study finds. A new study found no link between the use of a drug to treat an enlarged prostate and an increase in hip fractures in men.
Timing, Dosage of HRT Affect Chances of Heart Trouble
October 01, 2008
Large study found younger women taking it for a longer time did have higher risk. The largest observational study of hormone replacement therapy since the landmark Women's Health Initiative finds that how and when women take hormone replacement therapy affects their heart attack risk.
Hormone Therapy Not Best for Older Prostate Cancer Patients
September 23, 2008
Study found giving it before radiation raised death risk 20% in this group. Older men with early-stage prostate cancer who are given hormone therapy before radiation seed implant therapy face a 20 percent greater risk of dying than those who get radiation treatment alone, new research suggests.
HRT After Menopause Reduces Symptoms
August 22, 2008
It reduced problems with sleep, sexual functioning and hot flashes, study finds. Hormone replacement therapy, even when it's started many years after menopause, can reduce some of the quality-of-life problems caused by menopause, such as sleep problems and hot flashes.
Testosterone Associated With Disease Transmission
August 15, 2008
Mouse study finds hormone affects behavior, drives spread of contact illness. In mice, high levels of the male sex hormone testosterone may play an important role in the spread of disease, according to Penn State researchers.
HRT Drug Boosts Stroke Risk in Older Women
August 13, 2008
Tibolone should not be used by those 60 and older, study says. Women 60 and older taking the hormone-replacement therapy drug tibolone to relieve menopausal symptoms are at an increased risk for stroke, a new study finds.
Postmenopausal Women With Breast Cancer Face Joint Issues
August 12, 2008
Obesity, previous HRT, chemo also raised chances for those on endocrine treatment, study says. Postmenopausal women with breast cancer who are receiving endocrine treatment may be at increased risk of joint issues, including arthritis, a new study finds.
ED an Indicator of Men's Health
June 15, 2008
Dysfunction could be the 'portal' to heart problems, vascular disease, type 2 diabetes, study says.
Androgen Production Continues in Prostate Cancer Tumors
June 03, 2008
Growths are able to maintain significant testosterone levels despite therapy, study finds.
Men With Low Testosterone Not Receiving Treatment
May 27, 2008
Study finds patients with deficiency more likely to be poorer and without insurance.
Patch Form of HRT Poses Less Clotting Risks Than Pill Does
May 23, 2008
Analysis finds pill more than doubles risk while patch only increases it slightly.
Cholesterol Test Spots When HRT Raises Heart Risks
May 22, 2008
Ratio of 'good' to 'bad' cholesterol determined chances of trouble in postmenopausal women, study shows.
Gene Therapy May Treat Erectile Dysfunction
May 20, 2008
Studies in both men and monkeys show effectiveness of treatment.
Hormone Therapy Safe, Effective for Women Entering Menopause
May 20, 2008
Experts stress that the finding applies only to those under 60 years of age.
Pituitary Hormone May Boost Women's Heart Risk
April 29, 2008
Thyrotropin levels increasing even within normal range associated with dangers.
Stored Ovarian Tissue Needs Testing Before Re-Implantation
April 24, 2008
Inadequate safeguards could mean a return of cancer, study warns.
Heart Disease Risks Hit Boys in Teens
April 21, 2008
Girls protected by hormones during adolescence, study suggests.
Timing of HRT May Influence Heart Risks
April 16, 2008
Study found women with risk factors who took it early in menopause did not have diminished vessel function.
Breast Cancer Unchanged in Black Women, Despite Drop in HRT Use
April 15, 2008
More estrogen-receptor negative tumors may be a factor, experts suggest.
Testosterone Levels Among Financial Traders Affect Performance
April 14, 2008
British study found those with more of the male hormone in the morning made more money.
HRT Dosing May Determine Risks, Benefits
April 07, 2008
Rodent study finds higher levels of estrogen replacement proved more dangerous.
Testosterone Therapy May Reduce Bone Loss in Older Men
April 07, 2008
But long-term effects of the hormone treatment aren't known, researchers say.
Did Medicare Reimbursement Changes Affect Prostate Cancer Treatment?
April 07, 2008
Study suggests a link between less drug therapy and more surgical castration.
Hormone Combo May Provide Reversible Male Birth Control Tool
March 28, 2008
Testosterone coupled with progestin effectively suppressed sperm production.
Older Women Have Harder Time Preserving Muscle Than Men
March 26, 2008
Key difference appears to be how their bodies react to protein, study says.
HRT Raises Recurrence Risk Among Breast Cancer Survivors
March 25, 2008
Trial was halted early after risk of both recurrence and new malignancies surfaced.
Severe Menopause Symptoms Raise Heart Risks
March 14, 2008
The worse the symptoms, the higher the chances of trouble, study shows.
Older Men With Low Testosterone Face Greater Depression Risk
March 06, 2008
Three times more likely to have mood disorder than those with higher hormone levels
Raised Breast Cancer Risk Persists After Combo HRT Stopped
March 04, 2008
Latest data from Women's Health Initiative points to continued need for mammograms
HRT Can Lead to Abnormal Mammograms, Biopsies
February 25, 2008
That may limit effectiveness of these breast cancer detection methods, study says.
Hormone Therapy Only Helps Some Older Men With Prostate Cancer
January 22, 2008
Overall health profile, especially cardiovascular history, is determining factor, study finds.
Caffeine May Lower Ovarian Cancer Risk
January 22, 2008
Alcohol and cigarettes not seen as threat, new research reports.
HRT Raises Risk of Lobular Breast Cancer
January 16, 2008
Incidence increased with popularity of hormone therapy, study finds.
FDA Warns Against Bio-Identical Hormone Therapy
January 10, 2008
The menopause drugs are unregulated and could be dangerous, agency says.
Blood Markers Might Predict Clotting Risk With HRT
December 08, 2007
Postmenopausal women with high levels of D-dimer face greatest chance of trouble
Early HRT Protects a Woman's Heart
November 06, 2007
But contraceptives heighten risk of arterial problems, studies find.
HRT
A Boost for Libido, But Not Memory
September 24, 2007
Study of younger menopausal women found no difference in cognition between hormones and placebo.
Most Women Unaware of Hormone Replacement Study
September 21, 2007
Only 29% recall trial that cast doubt on supplemental estrogen's safety, study finds.
Flaxseed May Relieve Hot Flashes
August 31, 2007
Small Mayo Clinic pilot study shows 50% reduction over 6 weeks
Hormone Replacement May Raise Women's Gallbladder Risk
July 11, 2008
But taking the therapy in a non-oral form seems to cut the odds, study finds. A postmenopausal woman who uses hormone replacement therapy (HRT) may boost her risk for gallbladder disease, researchers say, although the risk appears to vary depending on how she receives the hormones.
Hormone Therapy Shows Little Benefit Against Prostate Cancer
July 08, 2008
Survival rates no different than 'watchful waiting,' study shows. An increasingly common therapy used for localized prostate cancer may not bestow any survival benefits on the patient beyond those seen with a simple "wait-and-see" approach.
